NCT02287168

Brief Summary

Surgical manipulation and handling of a tumor may cause dissemination of cancer cells through peritoneal cavity after curative gastrectomy. Intra operative peritoneal lavage may have preventive effect on positive peritoneal cytology occurred during gastrectomy in patients with gastric cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Oct 2014

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 31, 2014

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 10, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

March 29, 2016

Status Verified

March 1, 2016

Enrollment Period

1.2 years

First QC Date

October 31, 2014

Last Update Submit

March 26, 2016

Conditions

Keywords

Peritoneal lavageDisseminationGastrectomyCytologyLavage

Outcome Measures

Primary Outcomes (1)

  • elimination

    rate of conversion of positive cytology results to negative cytology by peritoneal lavage during the surgery

    at the operation

Secondary Outcomes (1)

  • dissemination

    at the operation

Study Arms (2)

dissemination of cancer cells

EXPERIMENTAL

conversion of negative result of pre-gastrectomy peritoneal washing cytology to positive cytology after gastrectomy

Procedure: pre-gastrectomy peritoneal washing cytologyProcedure: post-gastrectomy peritoneal washing cytology

elimination of cancer cells

EXPERIMENTAL

elimination of peritoneal cancer cells occurred before (pre-gastrectomy peritoneal washing cytology) or after gastrectomy (post-gastrectomy peritoneal washing cytology) by intra operative peritoneal lavage ('post-lavage peritoneal washing cytology)

Procedure: pre-gastrectomy peritoneal washing cytologyProcedure: post-gastrectomy peritoneal washing cytologyProcedure: post-lavage peritoneal washing cytology

Interventions

sampling of peritoneal washing fluid before gastrectomy

dissemination of cancer cellselimination of cancer cells

sampling of peritoneal washing fluid after gastrectomy

dissemination of cancer cellselimination of cancer cells

sampling of peritoneal washing fluid after peritoneal lavage

elimination of cancer cells

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Endoscopically proven gastric adenocarcinoma
  • Standard gastrectomy and a D2 lymph node dissection;
  • Desire to attend the study protocol

You may not qualify if:

  • Metastatic or overt peritoneal disseminated cancer
  • Undesired reaction to attend the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Bezmialem Vakif University Faculty of Medicine Dept of General Surgery

Istanbul, 34093, Turkey (Türkiye)

Location

Mustafa Hasbahceci

Istanbul, 34093, Turkey (Türkiye)

Location

Related Publications (7)

  • Yu XF, Ren ZG, Xue YW, Song HT, Wei YZ, Li CM. D2 lymphadenectomy can disseminate tumor cells into peritoneal cavity in patients with advanced gastric cancer. Neoplasma. 2013;60(2):174-81. doi: 10.4149/neo_2013_023.

    PMID: 23259786BACKGROUND
  • Shimada S, Kuramoto M, Marutsuka T, Yagi Y, Baba H. Adopting extensive intra-operative peritoneal lavage (EIPL) as the standard prophylactic strategy for peritoneal recurrence. Rev Recent Clin Trials. 2011 Sep;6(3):266-70. doi: 10.2174/157488711796575603.

    PMID: 21682671BACKGROUND
  • Yamamoto K, Shimada S, Hirota M, Yagi Y, Matsuda M, Baba H. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer. Int J Oncol. 2005 Nov;27(5):1321-8.

    PMID: 16211228BACKGROUND
  • Misawa K, Mochizuki Y, Ohashi N, Matsui T, Nakayama H, Tsuboi K, Sakai M, Ito S, Morita S, Kodera Y. A randomized phase III trial exploring the prognostic value of extensive intraoperative peritoneal lavage in addition to standard treatment for resectable advanced gastric cancer: CCOG 1102 study. Jpn J Clin Oncol. 2014 Jan;44(1):101-3. doi: 10.1093/jjco/hyt157. Epub 2013 Nov 27.

    PMID: 24287077BACKGROUND
  • Kuramoto M, Shimada S, Ikeshima S, Matsuo A, Yagi Y, Matsuda M, Yonemura Y, Baba H. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg. 2009 Aug;250(2):242-6. doi: 10.1097/SLA.0b013e3181b0c80e.

    PMID: 19638909BACKGROUND
  • Marutsuka T, Shimada S, Shiomori K, Hayashi N, Yagi Y, Yamane T, Ogawa M. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin Cancer Res. 2003 Feb;9(2):678-85.

    PMID: 12576435BACKGROUND
  • Shimada S, Tanaka E, Marutsuka T, Honmyo U, Tokunaga H, Yagi Y, Aoki N, Ogawa M. Extensive intraoperative peritoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cells. Gastric Cancer. 2002;5(3):168-72. doi: 10.1007/s101200200029.

    PMID: 12378344BACKGROUND

MeSH Terms

Conditions

Stomach Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach Diseases

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, general surgeon

Study Record Dates

First Submitted

October 31, 2014

First Posted

November 10, 2014

Study Start

October 1, 2014

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

March 29, 2016

Record last verified: 2016-03

Locations